Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.91−0.06 (-5.84%)
Close on Nov 17, 2026Market cap $47.67MP/E –Yield –
Rafael profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Rafael's profit margin for the twelve months ending Jul 31, 2026 was -3390.7%. For fiscal 2026 it was -3390.7%, against -3328.2% the year before. The highest annual figure on record is 12.7% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -3390.7% | −62.5 |
| FY2025 | Jul 31, 2025 | -3328.2% | +2073.6 |
| FY2024 | Jul 31, 2024 | -5401.9% | −4729.5 |
| FY2023 | Jul 31, 2023 | -672.4% | +29732.0 |
| FY2022 | Jul 31, 2022 | -30404.4% | −27529.0 |
| FY2021 | Jul 31, 2021 | -2875.4% | −2656.4 |
| FY2020 | Jul 31, 2020 | -219.0% | −123.8 |
| FY2019 | Jul 31, 2019 | -95.2% | +171.3 |
| FY2018 | Jul 31, 2018 | -266.5% | −269.0 |
| FY2017 | Jul 31, 2017 | 2.5% | −10.2 |
| FY2016 | Jul 31, 2016 | 12.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -3760.7% | −3677.8 |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -2360.9% | −1040.7 |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -3041.2% | +2986.0 |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -4090.0% | +2945.9 |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -82.9% | +2625.0 |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -1320.2% | +8308.1 |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -6027.3% | −14919.9 |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -7035.9% | −1685.9 |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -2707.9% | −4500.5 |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -9628.3% | −7604.3 |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | 8892.6% | +13535.5 |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -5350.0% | −7624.3 |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | 1792.6% | −16853.7 |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -2023.9% | +5276.1 |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -4642.9% | −1863.1 |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | 2274.3% | +69744.4 |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | 18646.4% | +19755.0 |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -7300.0% | −7032.3 |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -2779.7% | −1920.8 |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -67470.2% | −67334.3 |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -1108.7% | −645.5 |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -267.7% | −91.3 |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -858.9% | −757.5 |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -135.9% | −3.8 |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -463.1% | −307.2 |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -176.4% | −103.4 |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -101.4% | −1.0 |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -132.1% | −89.7 |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -155.9% | −103.7 |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -73.0% | −24.4 |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -100.4% | −43.3 |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -42.4% | +801.0 |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -52.3% | −46.6 |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -48.6% | −43.5 |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -57.1% | −69.5 |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -843.4% | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -5.7% | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -5.1% | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | 12.4% | – |
See a number that looks wrong?